查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696269

日本微生物培养市场 - 2025 至 2033 年

Japan Microbiology Culture Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年日本微生物培养市场规模达到 10.5718 亿美元，预计到 2033 年将达到 21.8582 亿美元，2025-2033 年预测期内的复合年增长率为 8.5%。

微生物培养是一种培养微生物以确定其身份、样本中的丰度或两者的方法。它是微生物学的主要诊断方法之一。培养微生物需要适当的物理环境，包括受控的 pH 值、大气气体、温度和压力。微生物培养基製备包括混合营养物质、缓衝剂、渗透平衡调节剂和选择性抑制剂或指示剂，以产生支持微生物生长和分化的琼脂或肉汤。该过程是微生物测试中监测腐败和致病微生物的常规任务。

市场动态：

驱动因素与约束因素

传染病发生率上升

传染病增加了对微生物培养技术的需求，因为准确的病原体鑑定、抗菌素抗药性测试和疾病监测对于早期诊断、治疗和疫情控制至关重要。

随着日本传染病数量的增加，对先进的诊断工具、研究和治疗开发的需求也日益增加。随着细菌、病毒和真菌感染的不断增加，医疗保健提供者和研究机构越来越依赖微生物培养来准确识别病原体、确定抗生素抗药性并制定有效的治疗策略。

日本支原体肺炎病例正在大幅增加，患者数量达到近十年来同期的最高水准。肺炎是日本第五大死因。例如，日本国立传染病研究所的资料显示，截至 2024 年 10 月的一周，全国平均每家医疗机构报告病例 2.01 例，这是该数字首次超过每家医疗机构 2 例。传染病数量的增加预计将增加对养殖设备、养殖补充剂和其他仪器的需求。因此，预计传染病数量的增加将推动该国市场的成长。

污染和结果不一致的风险

预计污染风险和不一致的结果将影响微生物培养的准确性和可靠性，从而阻碍日本微生物培养市场的成长。培养基製备、储存或处理过程中的污染会导致错误结果，从而损害诊断和研究结果的品质。不一致或不可靠的结果不仅会影响微生物检测的效率，还会增加误诊的风险，造成严重的公共卫生后果。这可能导致治疗延误、抗生素使用不当以及对结果缺乏信心，最终引起医疗保健专业人员和研究人员的担忧。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 按文化类型分类的片段
  • 一致性的片段
  • 按应用程式截取的程式码片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 传染病发生率上升
      • 增加微生物学和生命科学领域的研发投入
    • 限制
      • 严格的文化媒体生产规范架构
      • 污染和结果不一致的风险
    • 机会
      • 难培养微生物的创新培养基潜力
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 北美监管与报销格局
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：微生物培养市场（依产品类型）

  • 文化设备
    • 生物反应器
      • 生物反应器设备
      • 测量仪器
      • PH 感测器
      • 溶氧感知器
      • 温度感测器
      • 其他的
      • 分析设备
      • 细胞计数器
      • 光谱仪
      • 其他的
      • 灭菌设备
      • 孵化器
      • 其他的
  • 文化补编
  • 测量仪器
    • PH 感测器
    • 温度感测器
    • 溶氧感知器
    • 其他的
  • 文化仪器
    • 培养皿
    • 线圈与针
    • 微量移液器
    • 离心机
    • 其他的
  • 分析设备
    • 细胞计数器
    • 光谱仪
    • 其他的

第 6 章：微生物培养市场（依培养类型）

  • 真核培养
  • 细菌培养

第 7 章：微生物培养市场（按一致性）

  • 液体培养基
  • 固体培养基
  • 半固体培养基

第 8 章：微生物培养市场（按应用）

  • 药品
  • 食品饮料业
  • 水质检测
  • 化妆品

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • Merck KGaA
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Yokogawa Electric Corporation
  • SATAKE MultiMix Corporation
  • BEMARUBISHI CO., LTD.
  • ABLE Corporation & Biott Corporation
  • Eiken Chemical co. Lti.
  • BioMerieux SA
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Kerry Group plc.

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: BT9378

The Japan microbiology culture market reached US$ 1,057.18 million in 2024 and is expected to reach US$ 2,185.82 million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

Infectious diseases increase the demand for microbiology culture technologies, as accurate pathogen identification, antimicrobial resistance testing, and disease surveillance become essential for early diagnosis, treatment, and outbreak control.

With the increasing number of infectious diseases in Japan there is an increasing need for advanced diagnostic tools, research, and treatment development. With the growing number of bacterial, viral, and fungal infections, healthcare providers and research institutions are relying more on microbiology cultures to accurately identify pathogens, determine antibiotic resistance, and develop effective treatment strategies.

Japan is experiencing a significant rise in mycoplasma pneumonia cases, with patient numbers reaching the highest levels for this time of year in the past decade. Pneumonia was the fifth leading cause of death in Japan. For instance, data from Japan's National Institute of Infectious Diseases showed that, for the week ending October 2024, an average of 2.01 cases per medical institution were reported nationwide, marking the first time this figure surpassed two cases per facility. This increase in the number of infectious diseases is expected to increase the demand for culture equipment, culture supplements, and other instruments. Thus, the increasing number of infectious diseases is expected to drive the country's market growth.

Risk of Contamination and Inconsistent Results

The risk of contamination and inconsistent results is expected to hinder the growth of the Japan microbiology culture market by affecting the accuracy and reliability of microbial cultures. Contamination during the preparation, storage, or handling of culture media can lead to false results, compromising the quality of diagnostics and research outcomes. Inconsistent or unreliable results not only impact the efficiency of microbiological testing but also increase the risk of misdiagnosis, which can have serious public health consequences. This can lead to delays in treatment, improper use of antibiotics, and a lack of confidence in the results, ultimately raising concerns among healthcare professionals and researchers.

Segment Analysis

The Japan microbiology culture Market is segmented based on the product type, culture type, consistency, and application.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment in the product type segment is vital in the precise growth, isolation, and analysis of microorganisms. With the growing demand for advanced microbiological research, clinical diagnostics, and pharmaceutical development, the need for specialized culture equipment like incubators, autoclaves, and sterile handling instruments is becoming increasingly important.

Japan's advanced healthcare and biotechnology sectors require high-precision equipment to ensure the reliability of microbial culture processes. For various microbiology culturing and processing purposes, companies are introducing innovative microbiology culture solutions which is driving the segment's growth. For instance, in April 2023, Otsuka Techno Corporation, a subsidiary of Otsuka Pharmaceutical Factory, launched the OT-Algae, a resin-bag type microalgae culture device, as part of its environmentally friendly manufacturing efforts.

Competitive Landscape

The market players in the microbiology culture market are Merck KGaA, Yokogawa Electric Corporation, SATAKE MultiMix Corporation, B.E.MARUBISHI CO., LTD., ABLE Corporation & Biott Corporation, Eiken Chemical co. Lti., BioMerieux S.A., Thermo Fisher Scientific, Inc., Sartorius AG, and Kerry Group plc. among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
  • Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan microbiology culture market report would provide approximately 42 tables, 33t figures, and 180 pages.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Culture Type
  • 2.5. Snippet by Consistency
  • 2.6. Snippet by Application

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Infectious Diseases
      • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
      • 3.1.2.2. Risk of Contamination and Inconsistent Results
    • 3.1.3. Opportunity
      • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. North America Regulatory and Reimbursement Landscape
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Culture Equipment*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Bioreactors
      • 5.2.3.1. Bioreactor Devices
      • 5.2.3.2. Measuring Instruments
      • 5.2.3.2.1. PH Sensors
      • 5.2.3.2.2. Dissolved Oxygen Sensors
      • 5.2.3.2.3. Temperature Sensors
      • 5.2.3.2.4. Others
      • 5.2.3.3. Analytical Devices
      • 5.2.3.3.1. Cell Counters
      • 5.2.3.3.2. Spectrometers
      • 5.2.3.3.3. Others
      • 5.2.3.4. Sterilization Equipment
      • 5.2.3.5. Incubators
      • 5.2.3.6. Others
  • 5.3. Culture Supplements
  • 5.4. Measuring Instruments
    • 5.4.1. PH Sensors
    • 5.4.2. Temperature Sensors
    • 5.4.3. Dissolved Oxygen Sensors
    • 5.4.4. Others
  • 5.5. Culture Instruments
    • 5.5.1. Petri Dishes
    • 5.5.2. Loops & Needles
    • 5.5.3. Micropipettes
    • 5.5.4. Centrifuge
    • 5.5.5. Others
  • 5.6. Analytical Devices
    • 5.6.1. Cell Counters
    • 5.6.2. Spectrometers
    • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
    • 6.1.2. Market Attractiveness Index, By Culture Type
  • 6.2. Eukaryotic Culture*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
    • 7.1.2. Market Attractiveness Index, By Consistency
  • 7.2. Liquid Media*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Solid Culture Media
  • 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Food & Beverage Industry
  • 8.4. Water Testing
  • 8.5. Cosmetics

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Merck KGaA*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Yokogawa Electric Corporation
  • 10.3. SATAKE MultiMix Corporation
  • 10.4. B.E.MARUBISHI CO., LTD.
  • 10.5. ABLE Corporation & Biott Corporation
  • 10.6. Eiken Chemical co. Lti.
  • 10.7. BioMerieux S.A.
  • 10.8. Thermo Fisher Scientific, Inc.
  • 10.9. Sartorius AG
  • 10.10. Kerry Group plc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us